CD8A and cancer: CD8+ T cells are ubiquitous components of the TME and can differentiate into cytotoxic T lymphocytes (CTLs), which play an important role in the anti-cancer host response, with functional relevance for cancer immunotherapy [2,19,20,21,22,23,24,25,26].